S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
Log in

NYSEARCA:FTXH - First Trust Nasdaq Pharmaceuticals ETF Stock Price, Forecast & News

$22.94
+0.27 (+1.19 %)
(As of 12/12/2019 04:00 PM ET)
Add
Today's Range
$22.87
Now: $22.94
$22.97
50-Day Range
$20.57
MA: $21.78
$22.91
52-Week Range
$17.01
Now: $22.94
$22.97
Volume3,600 shs
Average Volume2,726 shs
Market Capitalization$9.18 million
P/E RatioN/A
Dividend Yield0.67%
BetaN/A

Basic Details

Issuer First Trust
Fund NameFirst Trust Nasdaq Pharmaceuticals ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:FTXH
Inception Date9/20/2016
Fund ManagerDaniel J. Lindquist, Jon C. Erickson, David G. McGarel, Roger F. Testin, Stan Ueland, Chris A. Peterson
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNasdaq US Smart Pharmaceuticals Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$9.08 million
Average Daily Volume$973.10
Discount/Premium-0.04%

ETF Expenses

Management Fee0.60%
Other Expenses0.00%
Total Expenses0.60%
Fee Waiver0.00%
Net Expenses0.60%

Administrator, Advisor and Custodian

AdministratorBrown Brothers Harriman & Co.
AdvisorFirst Trust Advisors L.P.
CustodianBrown Brothers Harriman & Co.
DistributorFirst Trust Portfolios L.P.
Transfer AgentBrown Brothers Harriman & Co.
Trustee
Lead Market MakerCredit Suisse

Receive FTXH News and Ratings via Email

Sign-up to receive the latest news and ratings for FTXH and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of First Trust Nasdaq Pharmaceuticals ETF (NYSEARCA:FTXH)
Currency Exposure of First Trust Nasdaq Pharmaceuticals ETF (NYSEARCA:FTXH)
Sector Exposure of First Trust Nasdaq Pharmaceuticals ETF (NYSEARCA:FTXH)
Industry Exposure of First Trust Nasdaq Pharmaceuticals ETF (NYSEARCA:FTXH)

First Trust Nasdaq Pharmaceuticals ETF (NYSEARCA:FTXH) Frequently Asked Questions

What is First Trust Nasdaq Pharmaceuticals ETF's stock symbol?

First Trust Nasdaq Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "FTXH."

Has First Trust Nasdaq Pharmaceuticals ETF been receiving favorable news coverage?

Press coverage about FTXH stock has been trending extremely negative recently, InfoTrie reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. First Trust Nasdaq Pharmaceuticals ETF earned a media sentiment score of -5.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for First Trust Nasdaq Pharmaceuticals ETF.

How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF?

Shares of FTXH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is First Trust Nasdaq Pharmaceuticals ETF's stock price today?

One share of FTXH stock can currently be purchased for approximately $22.94.

How big of a company is First Trust Nasdaq Pharmaceuticals ETF?

First Trust Nasdaq Pharmaceuticals ETF has a market capitalization of $9.18 million. View Additional Information About First Trust Nasdaq Pharmaceuticals ETF.


MarketBeat Community Rating for First Trust Nasdaq Pharmaceuticals ETF (NYSEARCA FTXH)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  4 (Vote Outperform)
Underperform Votes:  5 (Vote Underperform)
Total Votes:  9
MarketBeat's community ratings are surveys of what our community members think about First Trust Nasdaq Pharmaceuticals ETF and other stocks. Vote "Outperform" if you believe FTXH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FTXH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/12/2019 by MarketBeat.com Staff

Featured Article: 52-Week High/Low

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel